Ginkgo Bioworks Holdings Inc
NYSE:DNA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Ginkgo Bioworks Holdings Inc
NYSE:DNA
|
US |
|
Valero Energy Corp
NYSE:VLO
|
US |
|
JSR Corp
TSE:4185
|
JP |
|
Canadian Imperial Bank of Commerce
TSX:CM
|
CA |
|
Kirin Holdings Co Ltd
TSE:2503
|
JP |
|
I
|
Interpublic Group of Companies Inc
LSE:0JCK
|
US |
|
Safehold Inc
F:J0W
|
US |
|
Sealed Air Corp
NYSE:SEE
|
US |
|
L
|
Lands End Inc
F:LED
|
US |
|
Shiseido Co Ltd
TSE:4911
|
JP |
|
EDA Group Holdings Ltd
F:7OZ
|
CN |
|
F
|
First Tin PLC
F:1SN
|
UK |
|
Independence Realty Trust Inc
F:5O2
|
US |
|
Fox Corp
LSE:0A0X
|
US |
|
Cummins India Ltd
BSE:500480
|
IN |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
Wall St Price Targets
DNA Price Targets Summary
Ginkgo Bioworks Holdings Inc
According to Wall Street analysts, the average 1-year price target for
DNA is 9.18 USD with a low forecast of 9.09 USD and a high forecast of 9.45 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is DNA's stock price target?
Price Target
9.18
USD
According to Wall Street analysts, the average 1-year price target for
DNA is 9.18 USD with a low forecast of 9.09 USD and a high forecast of 9.45 USD.
What is the Revenue forecast for Ginkgo Bioworks Holdings Inc?
Projected CAGR
21%
Over the last 5 years, the compound annual growth rate for Revenue has been 17%. The projected CAGR for the next 3 years is 21%.
What is the Gross Profit forecast for Ginkgo Bioworks Holdings Inc?
Projected CAGR
24%
Over the last 5 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 3 years is 24%.